USP21-EGFR-Lyn axis drives NSCLC progression and therapeutic potential of USP21 inhibition
- Ji Hye Shin
- , Ji Young Kim
- , Mi Jeong Kim
- , Yeeun Kang
- , Bongkum Choi
- , Dohee Kwon
- , Yoolim Sung
- , Seo Hyun Kim
- , Ha Jeong Lee
- , Chaeeun Lee
- , Kyeong Kyu Kim
- , Jae Hyuck Shim
- , Duk Hwan Kim
- , Eunyoung Chun
- , Ki Young Lee
Research output: Contribution to journal › Letter › peer-review
4
Link opens in a new tab
Scopus
citations